Short answer
Definitive Healthcare Corp. (DH) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $60M (down 4.2% year over year) with net income of −$15M.
Q3 2025 key financials · XBRL
- Revenue
- $60M
- −4.2% YoY · −1.2% QoQ
- Net income
- −$15M
- +88.7% YoY · −96.5% QoQ
- Operating margin
- -14.5%
- Gross margin
- 76.6%
- EPS (diluted)
- −$0.15
- +86.6% YoY · −50.0% QoQ
Source: XBRL data from the Definitive Healthcare Corp. (DH) Q3 2025 10-Q on SEC EDGAR. USD.
Definitive Healthcare Corp. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New goodwill impairment risk triggered by Q1 2025 market cap decline, resulted in $176.5 million non-cash charge
- Sales execution risk materially updated due to 2024 restructuring plan disrupting sales, impacting customer acquisition and renewal rates in 2025
- Regulatory risk from sales tax misclassifications led to interest and penalties; resolved via voluntary disclosures and registrations
- Macroeconomic risk from prolonged deal cycles and customer churn, especially among smaller and Life Sciences customers, pressuring 2025 revenue growth
- Data acquisition cost risk increased due to 2024 healthcare claims data market disruptions, requiring renegotiation of agreements and new data sources
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Definitive Healthcare Corp. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.